Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Protagenic Therapeutics, Inc.\new (MPNC.OB) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Protagenic Therapeutics, Inc.\new. Table 2 shows the detailed insider transactions. This company's CIK number is 1022899.
Total stock buying since 2016: $103,833.
Total stock sales since 2016: $0.
Total stock option exercises since 2016: $540,000.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 8,000 | $6,480 | 0 | $0 | 0 | $0 |
| 2022 | 31,000 | $22,090 | 0 | $0 | 0 | $0 |
| 2021 | 0 | $0 | 0 | $0 | 360,000 | $540,000 |
| 2016 | 60,211 | $75,263 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-10 | 8,000 | $6,480 | 0 | $0 | 0 | $0 |
| 2022-05 | 31,000 | $22,090 | 0 | $0 | 0 | $0 |
| 2021-05 | 0 | $0 | 0 | $0 | 360,000 | $540,000 |
| 2016-06 | 60,211 | $75,263 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-10-12 | Arrow Alexander K. (Chief Financial Officer) | Buy | 8,000 | .81 | 6,480 |
| 2022-05-18 | Arrow Alexander K. (Chief Financial Officer) | Buy | 8,000 | .72 | 5,760 |
| 2022-05-17 | Arrow Alexander K. (Chief Financial Officer) | Buy | 23,000 | .71 | 16,330 |
| 2021-05-03 | Barrage Khalil | Option Ex | 360,000 | 1.50 | 540,000 |
| 2016-06-17 | Armen Garo H (See Remarks) | Buy | 60,211 | 1.25 | 75,263 |
Insider trading activities including stock purchases, stock sales, and option exercises of MPNC.OB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Protagenic Therapeutics, Inc.\new (symbol MPNC.OB, CIK number 1022899) see the Securities and Exchange Commission (SEC) website.